Global Myasthenia Gravis Market Research Report Forecast to 2023
Global Myasthenia Gravis Market is anticipated to witness a flourish annual growth rate of 9.61% during the estimated period (2018- 2023)
Myasthenia Gravis Market: By Type (Ocular Myasthenia Gravis, Congenital Myasthenia Gravis, Generalized Myasthenia Gravis, Transient Myasthenia Gravis, and Others), (Diagnosis and Treatment), End User (Hospitals and Clinics, Diagnostic Centers and Academic and Research Organizations) and By Region-Global Forecast Till 2023
Myasthenia gravis (MG) is an immune system neuromuscular illness, its essential effect incorporates a reduction in the convergence of AChRs on the muscle endplate membrane. North America and Latin America altogether make the biggest commitment to the development of the global myasthenia gravis market. In the meantime, Europe and the Asia Pacific hold the second and third spot regarding value. There has been a significant ascent in the predominance of myasthenia gravis as of late, which prompted a sharp increment in treatment request. The global myasthenia gravis market is anticipated to witness an annual growth rate of 9.61% during the estimated period (2018- 2023).
The global myasthenia gravis market has been segmented on the basis of its type, diagnosis and treatment, end-user and regional demand. Based on its type, the global myasthenia gravis market is segmented as Congenital myasthenia gravis, Ocular myasthenia gravis, Transient myasthenia gravis, Generalized myasthenia gravis, Others. Based on its diagnosis, the market is bifurcated into Electrodiagnostic testing & imaging and Lab-based test. On the basis of its treatment, the global myasthenia gravis market is divided into Immunosuppressive drugs, Cholinesterase inhibitors, Thymectomy, Plasmapheresis, and intravenous immunoglobulin. Based on its end-user industry, the market is divided into Hospitals and Clinics, Academic and Research organizations, Diagnostic Centers.
Geographically, the global myasthenia gravis market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.
CSL Behring, Medtronic Plc., Baxter, Grifols S.A., Shire, Koninklijke Philips N.V., and Valeant Pharmaceuticals International, Inc, GE Healthcare, Alexion Pharmaceuticals, Inc, Novartis AG, Pfizer Inc., Boston Scientific Corporation, among others are some of the major players in the global myasthenia gravis market.